- Home
- MED vs DHF Comparison
MED vs DHF Comparison
Compare MED & DHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MED
- DHF
- Stock Information
- Founded
- MED 1980
- DHF 1998
- Country
- MED United States
- DHF United States
- Employees
- MED N/A
- DHF N/A
- Industry
- MED Packaged Foods
- DHF Finance Companies
- Sector
- MED Consumer Staples
- DHF Finance
- Exchange
- MED Nasdaq
- DHF Nasdaq
- Market Cap
- MED 187.3M
- DHF 188.4M
- IPO Year
- MED N/A
- DHF N/A
- Fundamental
- Price
- MED $15.76
- DHF $2.63
- Analyst Decision
- MED Hold
- DHF
- Analyst Count
- MED 1
- DHF 0
- Target Price
- MED $17.00
- DHF N/A
- AVG Volume (30 Days)
- MED 223.4K
- DHF 451.1K
- Earning Date
- MED 02-18-2025
- DHF 01-01-0001
- Dividend Yield
- MED N/A
- DHF 7.65%
- EPS Growth
- MED N/A
- DHF N/A
- EPS
- MED 0.67
- DHF N/A
- Revenue
- MED $674,475,000.00
- DHF N/A
- Revenue This Year
- MED N/A
- DHF N/A
- Revenue Next Year
- MED N/A
- DHF N/A
- P/E Ratio
- MED $23.68
- DHF N/A
- Revenue Growth
- MED N/A
- DHF N/A
- 52 Week Low
- MED $14.94
- DHF $2.06
- 52 Week High
- MED $57.41
- DHF $2.39
- Technical
- Relative Strength Index (RSI)
- MED 39.99
- DHF 59.07
- Support Level
- MED $15.22
- DHF $2.53
- Resistance Level
- MED $15.93
- DHF $2.62
- Average True Range (ATR)
- MED 0.71
- DHF 0.03
- MACD
- MED 0.03
- DHF 0.01
- Stochastic Oscillator
- MED 28.47
- DHF 87.50
About MED MEDIFAST INC
Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.
About DHF BNY Mellon High Yield Strategies Fund
BNY Mellon High Yield Strategies Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income and its secondary objective is capital appreciation. It invests predominantly in fixed-income securities of below-investment-grade credit quality.